# LISINOPRIL and HYDROCHLOROTHIAZIDE

NDC: 51407-565
Generic name: LISINOPRIL and HYDROCHLOROTHIAZIDE
Labeler / Manufacturer: GSMS, Incorporated
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20250215

FDA application: ANDA076674

## Active ingredients

- HYDROCHLOROTHIAZIDE: 12.5 mg/1
- LISINOPRIL: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51407-565"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51407-565
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d02a0d38-676a-4e0f-9aa2-0a6c56cd7361